He and his colleagues employ pharmacologic, brain imaging, epidemiologic, genomic, and cell model approaches to study schizophrenia and bipolar disorder, in particular.
Treatment options have been limited and have included a multimodal approach that employed environmental management, behavioral modification and pharmacologic agents.